The Oncology Report

Published by: International Medical News Group LLC  

People

  1. Lichtman
    Lichtman

Groups

  1. Department of Medicine (38)
  2. Gynecologic Medicine Service (38)
  3. Solid Tumor Oncology Division (38)
Search Within
  1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (38)
Groups
  1. Department of Medicine (38)
  2. Gynecologic Medicine Service (38)
  3. Solid Tumor Oncology Division (38)
People
  1. Stuart Lichtman (38)
Years
  1. 2012 (1)
  2. 2011 (3)
  3. 2010 (4)
  4. 2007 (9)
  5. 2006 (9)
  6. 2005 (12)
Publishers
  1. International Medical News Group LLC (38)

Results (38)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Second-line bevacizumab adds weeks in metastatic CRC: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2012)

    Fulltext@MSK | Save
  • Neoadjuvant regimen fails to improve surgical outcomes: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2011)

    Fulltext@MSK | Save
  • Adjuvant capecitabine 'noninferior' to 5-FU in rectal Ca trial: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2011)

    Fulltext@MSK | Save
  • Comment: Most surgical patients tolerate oxaliplatin plus chemoradiation: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2011)

    Fulltext@MSK | Save
  • BRAF mutation predicts worse survival despite wild-type KRAS: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2010)

    Fulltext@MSK | Save
  • Survival better for CRC patients with liver metastases: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2010)

    Fulltext@MSK | Save
  • Geriatric oncology: Its time has come
    Journal Article

    Lichtman, S.
    The Oncology Report (2010)

    Fulltext@MSK | Save
  • Panitumumab enhances second-line FOLFIRI in phase III: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2010)

    Fulltext@MSK | Save
  • Cetuximab improves quality of life in advanced disease: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2007)

    Fulltext@MSK | Save
  • Perioperative FOLFOX4 improves survival with liver mets: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2007)

    Fulltext@MSK | Save

    • The Oncology Report – authorized name for:

    Name ISSN / ISBN Publisher
    Oncology Report 1548-5323 Unknown
    Oncology Report 15485323 Unknown
    Oncology Report 15485323 Elsevier Inc.
    The Oncology Report 1548-5323 International Medical News Group LLC
    The Oncology Report 1548-5323 International Medical News Group LLC